246 related articles for article (PubMed ID: 10987769)
1. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality.
Blanks RG; Moss SM; McGahan CE; Quinn MJ; Babb PJ
BMJ; 2000 Sep; 321(7262):665-9. PubMed ID: 10987769
[TBL] [Abstract][Full Text] [Related]
2. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries.
Quinn M; Allen E
BMJ; 1995 Nov; 311(7017):1391-5. PubMed ID: 8520272
[TBL] [Abstract][Full Text] [Related]
3. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.
Johns LE; Coleman DA; Swerdlow AJ; Moss SM
Br J Cancer; 2017 Jan; 116(2):246-252. PubMed ID: 27931047
[TBL] [Abstract][Full Text] [Related]
4. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
[TBL] [Abstract][Full Text] [Related]
5. 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer.
Lancet; 1999 Jun; 353(9168):1909-14. PubMed ID: 10371568
[TBL] [Abstract][Full Text] [Related]
6. The effect of service screening on breast cancer mortality rates.
Cox B
Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
[TBL] [Abstract][Full Text] [Related]
7. The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods.
Mandelblatt J; Schechter CB; Lawrence W; Yi B; Cullen J
J Natl Cancer Inst Monogr; 2006; (36):47-55. PubMed ID: 17032894
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effect on breast cancer mortality of population based mammography screening programmes.
Törnberg S; Carstensen J; Hakulinen T; Lenner P; Hatschek T; Lundgren B
J Med Screen; 1994 Jul; 1(3):184-7. PubMed ID: 8790514
[TBL] [Abstract][Full Text] [Related]
9. Effect of population breast screening on breast cancer mortality to 2005 in England and Wales: A nested case-control study within a cohort of one million women.
Johns LE; Swerdlow AJ; Moss SM
J Med Screen; 2018 Jun; 25(2):76-81. PubMed ID: 28675954
[TBL] [Abstract][Full Text] [Related]
10. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
Jonsson H; Nyström L; Törnberg S; Lenner P
J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
[TBL] [Abstract][Full Text] [Related]
11. The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales.
Waller M; Moss S; Watson J; Møller H
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2257-61. PubMed ID: 18006913
[TBL] [Abstract][Full Text] [Related]
12. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales.
Fielder HM; Warwick J; Brook D; Gower-Thomas K; Cuzick J; Monypenny I; Duffy SW
J Med Screen; 2004; 11(4):194-8. PubMed ID: 15563774
[TBL] [Abstract][Full Text] [Related]
13. Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies.
Herrmann C; Vounatsou P; Thürlimann B; Probst-Hensch N; Rothermundt C; Ess S
BMJ Open; 2018 Mar; 8(3):e017806. PubMed ID: 29540406
[TBL] [Abstract][Full Text] [Related]
14. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
15. Reduction in breast cancer mortality due to the introduction of mass screening in The Netherlands: comparison with the United Kingdom.
van den Akker-van Marle E; de Koning H; Boer R; van der Maas P
J Med Screen; 1999; 6(1):30-4. PubMed ID: 10321368
[TBL] [Abstract][Full Text] [Related]
16. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.
Moss S
J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845
[TBL] [Abstract][Full Text] [Related]
17. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study.
Morrell S; Taylor R; Roder D; Dobson A
J Med Screen; 2012 Mar; 19(1):26-34. PubMed ID: 22345322
[TBL] [Abstract][Full Text] [Related]
18. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg.
Nyström L; Bjurstam N; Jonsson H; Zackrisson S; Frisell J
J Med Screen; 2017 Mar; 24(1):34-42. PubMed ID: 27306511
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
[TBL] [Abstract][Full Text] [Related]
20. Mammography screening and breast cancer mortality in New South Wales, Australia.
Taylor R; Morrell S; Estoesta J; Brassil A
Cancer Causes Control; 2004 Aug; 15(6):543-50. PubMed ID: 15280633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
